FDC Limited (FDC.BO)
INR 514.15
(-0.08%)
INR 514.15
(-0.08%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 24.68 Billion INR | 5.34% |
| 2022 | 23.42 Billion INR | 3.2% |
| 2021 | 22.7 Billion INR | 16.05% |
| 2020 | 19.56 Billion INR | 7.9% |
| 2019 | 18.12 Billion INR | 10.55% |
| 2018 | 16.39 Billion INR | 8.95% |
| 2017 | 15.05 Billion INR | 2.54% |
| 2016 | 14.67 Billion INR | 15.97% |
| 2015 | 12.65 Billion INR | 8.0% |
| 2014 | 11.72 Billion INR | 10.66% |
| 2013 | 10.59 Billion INR | 9.62% |
| 2012 | 9.66 Billion INR | 11.99% |
| 2011 | 8.62 Billion INR | 12.11% |
| 2010 | 7.69 Billion INR | 13.27% |
| 2009 | 6.79 Billion INR | 24.38% |
| 2008 | 5.46 Billion INR | 9.59% |
| 2007 | 4.98 Billion INR | 20.97% |
| 2006 | 4.12 Billion INR | 14.13% |
| 2005 | 3.61 Billion INR | 14.24% |
| 2004 | 3.16 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 24.68 Billion INR | 5.34% |
| 2023 Q4 | 24.68 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 23.41 Billion INR | 0.0% |
| 2022 FY | 23.42 Billion INR | 3.2% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 22.97 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 23.42 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 22.7 Billion INR | 0.0% |
| 2021 FY | 22.7 Billion INR | 16.05% |
| 2021 Q2 | 22.23 Billion INR | 0.0% |
| 2020 Q2 | 20.01 Billion INR | 0.0% |
| 2020 FY | 19.56 Billion INR | 7.9% |
| 2020 Q4 | 19.56 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q4 | 18.12 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 18.12 Billion INR | 10.55% |
| 2019 Q2 | 17.05 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q4 | 16.39 Billion INR | 0.0% |
| 2018 FY | 16.39 Billion INR | 8.95% |
| 2017 FY | 15.05 Billion INR | 2.54% |
| 2016 FY | 14.67 Billion INR | 15.97% |
| 2015 FY | 12.65 Billion INR | 8.0% |
| 2014 FY | 11.72 Billion INR | 10.66% |
| 2013 FY | 10.59 Billion INR | 9.62% |
| 2012 FY | 9.66 Billion INR | 11.99% |
| 2011 FY | 8.62 Billion INR | 12.11% |
| 2010 FY | 7.69 Billion INR | 13.27% |
| 2009 FY | 6.79 Billion INR | 24.38% |
| 2008 FY | 5.46 Billion INR | 9.59% |
| 2007 FY | 4.98 Billion INR | 20.97% |
| 2006 FY | 4.12 Billion INR | 14.13% |
| 2005 FY | 3.61 Billion INR | 14.24% |
| 2004 FY | 3.16 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Ajanta Pharma Limited | 46.38 Billion INR | 46.79% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -572.741% |
| Sigachi Industries Limited | 6.94 Billion INR | -255.552% |
| Bal Pharma Limited | 3.2 Billion INR | -670.342% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -111.834% |
| Medico Remedies Limited | 961.95 Million INR | -2465.707% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -1535.919% |
| Venus Remedies Limited | 6.26 Billion INR | -293.741% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -379.204% |
| Alpa Laboratories Limited | 1.82 Billion INR | -1251.477% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -12.644% |
| Shilpa Medicare Limited | 30.93 Billion INR | 20.209% |
| Aarti Drugs Limited | 24.32 Billion INR | -1.469% |
| Lupin Limited | 239.97 Billion INR | 89.715% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 94.524% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 91.571% |
| Windlas Biotech Limited | 6.26 Billion INR | -294.134% |
| Suven Life Sciences Limited | 2.84 Billion INR | -766.292% |
| Eris Lifesciences Limited | 70.48 Billion INR | 64.986% |
| Valiant Laboratories Limited | 3.42 Billion INR | -620.216% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 38.207% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | -4.982% |
| Ipca Laboratories Limited | 111.01 Billion INR | 77.768% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -103.324% |
| Achyut Healthcare Limited | 309.52 Million INR | -7873.875% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 97.112% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -222.572% |
| RPG Life Sciences Limited | 5.12 Billion INR | -381.231% |
| Mankind Pharma Limited | 119.63 Billion INR | 79.369% |
| Laurus Labs Limited | 83.87 Billion INR | 70.573% |
| Piramal Pharma Limited | 153.11 Billion INR | 83.881% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -509.911% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 83.613% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 61.709% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 82.811% |
| Unichem Laboratories Limited | 31.69 Billion INR | 22.126% |
| Sequent Scientific Limited | 15.4 Billion INR | -60.226% |
| Novartis India Limited | 9.24 Billion INR | -166.841% |
| Wanbury Limited | 3.43 Billion INR | -618.527% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -9.494% |
| Wockhardt Limited | 76.49 Billion INR | 67.733% |
| Themis Medicare Limited | 5.66 Billion INR | -335.738% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -1036.96% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 78.628% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 13.413% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 93.631% |
| Divi's Laboratories Limited | 154.7 Billion INR | 84.046% |
| NATCO Pharma Limited | 69.06 Billion INR | 64.263% |
| Gufic Biosciences Limited | 10.92 Billion INR | -125.904% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -9.967% |
| Ind-Swift Limited | 6.54 Billion INR | -277.112% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -210.702% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -1285.208% |
| Granules India Limited | 55.2 Billion INR | 55.296% |
| Medicamen Biotech Limited | 2.94 Billion INR | -737.997% |
| Alkem Laboratories Limited | 155.74 Billion INR | 84.153% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -128.945% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -5142.031% |
| Brooks Laboratories Limited | 904.45 Million INR | -2628.817% |
| Megasoft Limited | 3.65 Billion INR | -574.526% |
| ZIM Laboratories Limited | 4.46 Billion INR | -452.365% |
| Strides Pharma Science Limited | 58.39 Billion INR | 57.736% |
| Neuland Laboratories Limited | 18.32 Billion INR | -34.68% |
| Morepen Laboratories Limited | 12.93 Billion INR | -90.851% |
| Hikal Limited | 24.87 Billion INR | 0.766% |
| Indoco Remedies Limited | 21.44 Billion INR | -15.077% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 4.415% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -928.107% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -640.225% |
| Hester Biosciences Limited | 6.62 Billion INR | -272.628% |